490 results on '"Block, Timothy"'
Search Results
2. Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study
3. “PROTAC” modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitro
4. Implications of Circulating Hepatitis B Virus RNA Levels in Assessment of Response to Antiviral Therapy
5. Use of Targeted Glycoproteomics to Identify Serum Glycoproteins That Correlate with Liver Cancer in Woodchucks and Humans
6. Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics
7. Imino Sugars Inhibit the Formation and Secretion of Bovine Viral Diarrhea Virus, a Pestivirus Model of Hepatitis C Virus: Implications for the Development of Broad Spectrum Anti-Hepatitis Virus Agents
8. Aberrant Trafficking of Hepatitis B Virus Glycoproteins in Cells in which N-Glycan Processing is Inhibited
9. Hepatitis B Virus (HBV) Envelope Glycoproteins Vary Drastically in their Sensitivity to Glycan Processing: Evidence that Alteration of a Single N-Linked Glycosylation Site can Regulate HBV Secretion
10. Elizabethkingia anophelis: Clinical Experience of an Academic Health System in Southeastern Wisconsin
11. Calcium Phosphate Particles as Pulmonary Delivery System for Interferon-α in Mice
12. An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses
13. A research agenda for curing chronic hepatitis B virus infection
14. Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop
15. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo
16. HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element
17. Interferon induction of IFITM proteins promotes infection by human coronavirus OC43
18. Opportunities to address gaps in early detection and improve outcomes of liver cancer.
19. Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions
20. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
21. Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system
22. Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care
23. Vascular flora and community assemblages of Delhaas Woods, a coastal plain forest in Bucks County, Pennsylvania
24. The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy
25. The hepatitis B epidemic and the urgent need for cure preparedness
26. Vascular Flora and Community Assemblages of Evansburg State Park, Montgomery County, Pennsylvania
27. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo
28. A historical perspective on the discovery and elucidation of the hepatitis B virus
29. Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma.
30. Present and Future Therapies of Hepatitis B: From Discovery to Cure
31. Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis
32. Data Supporting Updating Estimates of the Prevalence of Chronic Hepatitis B and C in the United States
33. CHAPTER SEVEN Glycosylation and Liver Cancer
34. Antiviral effect of interferon lambda against West Nile virus
35. Antiviral activity of geneticin against dengue virus
36. Rapid and sensitive detection of hepatitis B virus 1762T/1764A double mutation from hepatocellular carcinomas using LNA-mediated PCR clamping and hybridization probes
37. Secretion of Human Hepatitis B Virus is Inhibited by the Imino Sugar N- Butyldeoxynojirimycin
38. Direct evidence that HSV DNA damaged by ultraviolet (UV) irradiation can be repaired in a cell type-dependent manner
39. Evidence that herpes simplex virus DNA derived from quiescently infected cellsin vitro, and latently infected cellsin vivo, is physically damaged
40. Two Cases of Recovery of Dimorphic Pathogenic Fungi via Conventional BacT/ALERT® Microbial Detection System Media
41. Tumor-associated protein SPIK/TATI suppresses serine protease dependent cell apoptosis
42. Herpes simplex virus type 1 ICP4 deletion mutant virus d120 infection failed to induce apoptosis in nerve growth factor-differentiated PC12 cells
43. The stability of herpes simplex virus type I genomes in infected Vero cells undergoing viral induced apoptosis
44. Molecular Virology of Hepatitis B Virus for Clinicians
45. Alpha interferon-induced antiviral response noncytolytically reduces replication defective adenovirus DNA in MDBK cells
46. Molecular viral oncology of hepatocellular carcinoma
47. Chronic hepatitis B: What should be the goal for new therapies?
48. Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays
49. Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen
50. Substance Abuse, HIV-1 and Hepatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.